These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 36845135
1. An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome. Gastoldi S, Aiello S, Galbusera M, Breno M, Alberti M, Bresin E, Mele C, Piras R, Liguori L, Santarsiero D, Benigni A, Remuzzi G, Noris M. Front Immunol; 2023; 14():1112257. PubMed ID: 36845135 [Abstract] [Full Text] [Related]
2. Modeling complement activation on human glomerular microvascular endothelial cells. Stevens KH, Baas LM, van der Velden TJAM, Bouwmeester RN, van Dillen N, Dorresteijn EM, van Zuilen AD, Wetzels JFM, Michels MAHM, van de Kar NCAJ, van den Heuvel LP. Front Immunol; 2023; 14():1206409. PubMed ID: 37954621 [Abstract] [Full Text] [Related]
4. Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant. Piras R, Iatropoulos P, Bresin E, Todeschini M, Gastoldi S, Valoti E, Alberti M, Mele C, Galbusera M, Cuccarolo P, Benigni A, Remuzzi G, Noris M. Front Med (Lausanne); 2020; 7():579418. PubMed ID: 33224962 [Abstract] [Full Text] [Related]
5. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E, Tripodo C, Bettoni S, Donadelli R, Valoti E, Tedesco F, Amore A, Coppo R, Ruggenenti P, Gotti E, Remuzzi G. Blood; 2014 Sep 11; 124(11):1715-26. PubMed ID: 25037630 [Abstract] [Full Text] [Related]
6. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome. Goicoechea de Jorge E, Tortajada A, García SP, Gastoldi S, Merinero HM, García-Fernández J, Arjona E, Cao M, Remuzzi G, Noris M, Rodríguez de Córdoba S. J Am Soc Nephrol; 2018 Jan 11; 29(1):240-249. PubMed ID: 28993505 [Abstract] [Full Text] [Related]
9. Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study. Duineveld C, Bouwmeester RN, van den Heuvel LPWJ, van de Kar NCAJ, Wetzels JFM. Kidney Int Rep; 2024 Jan 11; 9(1):145-151. PubMed ID: 38312782 [Abstract] [Full Text] [Related]
11. Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome. Magro CM, Momtahen S, Mulvey JJ, Yassin AH, Kaplan RB, Laurence JC. Am J Dermatopathol; 2015 May 11; 37(5):349-56; quiz 357-9. PubMed ID: 25893747 [Abstract] [Full Text] [Related]
12. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome. Bu F, Zhang Y, Wang K, Borsa NG, Jones MB, Taylor AO, Takanami E, Meyer NC, Frees K, Thomas CP, Nester C, Smith RJH. J Am Soc Nephrol; 2018 Dec 11; 29(12):2809-2819. PubMed ID: 30377230 [Abstract] [Full Text] [Related]
13. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation. Valoti E, Alberti M, Tortajada A, Garcia-Fernandez J, Gastoldi S, Besso L, Bresin E, Remuzzi G, Rodriguez de Cordoba S, Noris M. J Am Soc Nephrol; 2015 Jan 11; 26(1):209-19. PubMed ID: 24904082 [Abstract] [Full Text] [Related]
15. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome. Hyvärinen S, Meri S, Jokiranta TS. Blood; 2016 Jun 02; 127(22):2701-10. PubMed ID: 27006390 [Abstract] [Full Text] [Related]
16. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation. Ueda Y, Miwa T, Ito D, Kim H, Sato S, Gullipalli D, Zhou L, Golla M, Song D, Dunaief JL, Palmer MB, Song WC. Kidney Int; 2019 Jul 02; 96(1):67-79. PubMed ID: 30910380 [Abstract] [Full Text] [Related]
17. Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy. Martin M, Llorens-Cebria C, León-Román J, Perurena-Prieto J, Perez-Beltran V, Saumell S, Torres IB, Agraz I, Sellarès J, Ramos N, Bestard O, López M, Moreso F, Ariceta G, Soler MJ, Hernandez-Gonzalez M, Jacobs-Cachá C. Kidney Int Rep; 2024 Jul 02; 9(7):2227-2239. PubMed ID: 39081726 [Abstract] [Full Text] [Related]
18. Complement Factor I Variants in Complement-Mediated Renal Diseases. Zhang Y, Goodfellow RX, Ghiringhelli Borsa N, Dunlop HC, Presti SA, Meyer NC, Shao D, Roberts SM, Jones MB, Pitcher GR, Taylor AO, Nester CM, Smith RJH. Front Immunol; 2022 Jul 02; 13():866330. PubMed ID: 35619721 [Abstract] [Full Text] [Related]
19. Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome. Gholizad-Kolveiri S, Hooman N, Alizadeh R, Hoseini R, Otukesh H, Talebi S, Akouchekian M. BMC Med Genet; 2020 Aug 24; 21(1):169. PubMed ID: 32838746 [Abstract] [Full Text] [Related]
20. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ. J Am Soc Nephrol; 2014 Jan 24; 25(1):55-64. PubMed ID: 24029428 [Abstract] [Full Text] [Related] Page: [Next] [New Search]